(S (NP (NP (JJ Modern) (NNS treatments)) (PP (IN for) (NP (NML (NN Type) (NML (CD 1) (NN diabetes) (PRN (-LRB- -LRB-) (NP (NN T1D)) (-RRB- -RRB-)))) (NN use) (NNS devices)))) (VP (VBN known) (PP (IN as) (NP (NP (NP (JJ artificial) (NN pancreata)) (-LRB- -LRB-) (NP (NNS APs)) (-RRB- -RRB-)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP combine) (NP (DT an) (NN insulin) (NN pump)) (PP (IN with) (NP (NP (DT a) (JJ continuous) (NML (NML (NN glucose) (NN monitor)) (-LRB- -LRB-) (NML (NN CGM)) (-RRB- -RRB-)) (NN operating)) (PP (IN in) (NP (DT a) (NML (JJ closed) (HYPH -) (NN loop)) (NN manner))))) (S (VP (TO to) (VP (VB control) (NP (NML (NN blood) (NN glucose)) (NNS levels))))))))))) (. .))
(S (PP (IN In) (NP (NN practice))) (, ,) (NP (NP (JJ poor) (NN performance)) (PP (IN of) (NP (NP (NNS APs)) (-LRB- -LRB-) (NP (JJ frequent) (ADJP (JJ hyper) (HYPH -) (CC or) (JJ hypoglycemic)) (NNS events)) (-RRB- -RRB-)))) (VP (VBZ is) (ADJP (ADJP (JJ common) (RB enough)) (PP (IN at) (NP (DT a) (NN population) (NN level)))) (SBAR (WHNP (WDT that)) (S (NP (JJ many) (NN T1D) (NNS patients)) (VP (VBP modify) (NP (DT the) (NNS algorithms)) (PP (IN on) (NP (NP (VBG existing) (NN AP) (NNS systems)) (PP (IN with) (NP (JJ unregulated) (NML (JJ open) (HYPH -) (NN source)) (NN software))))))))) (. .))
(S (S (ADVP (RB Anecdotally)) (, ,) (NP (NP (DT the) (NNS patients)) (PP (IN in) (NP (DT this) (NN group)))) (VP (VBP have) (VP (VBN shown) (NP (JJ superior) (NNS outcomes)) (PP (VBN compared) (PP (IN with) (NP (NP (NN standard)) (PP (IN of) (NP (NN care))))))))) (, ,) (CC yet) (S (NP (PRP we)) (VP (VBP do) (RB not) (VP (VB understand) (SBAR (WHADJP (WRB how) (JJ safe)) (S (NP (DT any) (NN AP) (NN system)) (VP (VBZ is) (SBAR (IN since) (S (NP (JJ adverse) (NNS outcomes)) (VP (VBP are) (ADJP (JJ rare))))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP construct) (NP (NP (JJ generative) (NNS models)) (PP (IN of) (NP (NP (NP (JJ individual) (NNS patients) (POS ')) (JJ physiological) (NNS characteristics)) (CC and) (NP (VBG eating) (NNS behaviors)))))) (. .))
(S (NP (PRP We)) (ADVP (RB then)) (VP (VBP couple) (NP (DT these) (NNS models)) (PP (IN with) (NP (NP (DT a) (NN T1D) (NN simulator)) (VP (VBN approved) (PP (IN for) (NP (JJ pre-clinical) (NNS trials))) (PP (IN by) (NP (DT the) (NNP FDA))))))) (. .))
(S (PP (VBN Given) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB simulate) (NP (JJ patient) (NNS outcomes)) (PP (IN in) (HYPH -) (ADVP (FW silico)))))))) (, ,) (NP (PRP we)) (VP (VBP utilize) (NP (NNS techniques)) (PP (IN from) (NP (NP (NML (JJ rare) (HYPH -) (NN event)) (NN simulation) (NN theory)) (PP (IN in) (NP (NN order))))) (S (VP (TO to) (ADVP (RB efficiently)) (VP (VB quantify) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NP (DT a) (NN device)) (PP (IN with) (NP (NN respect)))))) (PP (IN to) (NP (DT a) (JJ particular) (NN patient))))))) (. .))
(S (PP (IN In) (NP (NN practice))) (NP (PRP$ our) (NN toolchain)) (VP (VBZ enables) (NP (NP (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (JJ hypoglycemic) (NNS events)))))) (PP (IN with) (NP (NP (RB approximately) (DT an) (NN order)) (PP (IN of) (NP (NP (NN magnitude)) (NP (JJR fewer) (NNS simulations))))))) (. .))
